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Abstract
Background: Previously, a bovine intestinal epithelial cell line (BIE cells) was successfully established. This work
hypothesized that BIE cells are useful in vitro model system for the study of interactions of microbial- or pathogen-
associated molecular patterns (MAMPs or PAMPs) with bovine intestinal epithelial cells and for the selection of
immunoregulatory lactic acid bacteria (LAB).
Results: All toll-like receptor (TLR) genes were expressed in BIE cells, being TLR4 one of the most strongly expressed.
We demonstrated that heat-stable PAMPs of enterotoxigenic Escherichia coli (ETEC) significantly enhanced the
production of IL-6, IL-8, IL-1α and MCP-1 in BIE cells by activating both NF-κB and MAPK pathways. We evaluated the
capacity of several lactobacilli strains to modulate heat-stable ETEC PAMPs-mediated inflammatory response in BIE
cells. Among these strains evaluated, Lactobacillus casei OLL2768 attenuated heat-stable ETEC PAMPs-induced
pro-inflammatory response by inhibiting NF-κB and p38 signaling pathways in BIE cells. Moreover, L. casei OLL2768
negatively regulated TLR4 signaling in BIE cells by up-regulating Toll interacting protein (Tollip) and B-cell lymphoma
3-encoded protein (Bcl-3).
Conclusions: BIE cells are suitable for the selection of immunoregulatory LAB and for studying the mechanisms
involved in the protective activity of immunobiotics against pathogen-induced inflammatory damage. In addition, we
showed that L. casei OLL2768 functionally modulate the bovine intestinal epithelium by attenuating heat-stable ETEC
PAMPs-induced inflammation. Therefore L. casei OLL2768 is a good candidate for in vivo studying the protective effect
of LAB against intestinal inflammatory damage induced by ETEC infection or heat-stable ETEC PAMPs challenge in the
bovine host.
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Background
Enterotoxigenic Escherichia coli (ETEC) are pathogenic
bacteria that are able to infect humans and several spe-
cies of animals. In farm animals such as cattle, ETEC in-
fection results in reduced growth rate, increased
mortality and economic loss [1]. ETEC interacts with in-
testinal epithelial cells (IECs), colonizes the small intes-
tine and secretes enterotoxins inducing intestinal acute
diarrhea and inflammation [2,3]. In addition to its cap-
acity to infect cells and induce damage through toxins,
ETEC are able to induce an inflammatory response
through other pathogen-associated molecular patterns
(PAMPs) such as lipopolysaccharide (LPS) that contrib-
ute to cellular and tissue damage during infections [2,4].
ETEC is able to trigger toll-like receptor (TLR)-4 activa-
tion and cytokines production by IECs and induce the
recruitment and activation of inflammatory cells. Al-
though this mechanism represent an important primary
line of host defense, a prolonged or non-regulated pro-
inflammatory cytokines production may lead to tissue
damage and epithelial barrier disfunction [1,4,5]. There-
fore, during ETEC infection it is imperative to generate
an adequate inflammatory response against the patho-
gen, accompanied by efficient regulation, in order to
achieve protection without damaging host tissues.
Probiotics have been defined as “live microorganisms
which when administered in adequate amounts confer a
health benefit on the host” [6]. Several lactic acid bacteria
(LAB) strains are considered beneficial to the host and as
such have been used as probiotics and included in several
functional foods. Modulation of host immunity is one of
the most commonly alleged benefits of the consumption
of probiotics. The term immunobiotics has been proposed
for those probiotic strains with immunoregulatory activ-
ities [7]. Studies have shown that immunobiotics can
beneficially modulate the immune response against ETEC
[8-11]. Roselli et al. [8] showed that Bifidobacterium
animalis MB5 and Lactobacillus rhamnosus GG protect
intestinal Caco-2 cells from the inflammation-associated
response caused by ETEC K88 by partly reducing patho-
gen adhesion and by counteracting neutrophil migration.
Moreover, experiments in Caco-2 cells demonstrated that
L. rhamnosus GG is able to counteract the ETEC-induced
up-regulation of interleukin (IL)-1β and tumor necrosis
factor (TNF), and the down-regulation of transforming
growth factor β1 (TGF-β1) expression, and consequently
to block the cytokine deregulation [9]. In addition,
comparative studies between L. rhamnosus GG and B.
animalis MB5, demonstrated that individual strains of
probiotics have a different impact on the inflammatory re-
sponse triggered in IECs [9]. Others studies evaluating the
effect of probiotic yeasts showed that Saccharomyces
cerevisiae CNCM I-3856 decreased the expression of
pro-inflammatory mediators IL-6, IL-8, CCL20, CXCL2,
CXCL10 in porcine intestinal epithelial IPI-2I cells cul-
tured with F4+ ETEC [10]. Moreover, it was demonstrated
that the CNCM I-3856 strain inhibits ETEC-induced
expression of pro-inflammatory cytokines and chemokines
transcripts and proteins and that this inhibition was asso-
ciated to a decrease of ERK1/2 and p38 mitogen-activated
protein kinases (MAPK) phosphorylation and to an
increase of the anti-inflammatory peroxisome proliferator-
activated receptor-γmRNA level [11].
There is increasing research in the use of probiotics for
decreasing pathogen load and ameliorating gastrointes-
tinal disease symptoms in animals [12-15]. Several studies
were conducted in vivo utilizing different probiotic strains
to evaluate the effect of immunobiotics against ETEC in-
fection, however the majority of these studies were
performed in swine and only few in the cattle [12]. Beside
the in vivo studies, several in vitro tests can be performed
to identify the best potential probiotics. In this sense, we
have recently demonstrated that the combination of the
nuclear factor κ B (NF-κB)-reporter assay using a porcine
TLR2-expressing transfectant (HEKpTLR2 system), the
mitogenic assay using porcine Peyer’s patches immuno-
competent cells and the evaluation of anti-inflammatory
activities of LAB in porcine intestinal epithelial (PIE) cell
line are useful tools to select potential probiotic strains
[13]. Moreover, we showed that PIE cells can be used to
study the mechanisms involved in the protective activity
of immunobiotics against intestinal inflammatory damage
and may provide useful information for the development
of new immunologically functional feeds that help to pre-
vent inflammatory intestinal disorders, including weaning-
associated intestinal inflammation in pigs [14,15]. There-
fore the use of probiotics in animal feeding could be en-
hanced by preliminarly in vitro screening such as the
production of inhibitory substances, survival in the gastro-
intestinal tract and antibiotic susceptibility [16] that can
be analyzed to evaluate functionality and safety [12].
Moreover, the use of probiotics in cattle could be im-
proved by the development of in vitro systems specific for
cattle that allow the simply and efficient assess of the im-
munomodulatory activity of the potential probiotic LAB
strains.
Recently we have successfully established a bovine intes-
tinal epithelial cell line (BIE cells) [17]. We hypothesized
that BIE cells are useful in vitro model system for the
study of interactions between pathogens and bovine IECs,
for the selection of immunobiotic microorganisms and for
the study of the mechanisms of immunomodulation by
probiotic LAB in IECs. Therefore, the aims of the present
study were: i) to assess the capability of BIE cells to re-
spond to the challenge with heat-stable ETEC PAMPs,
considering the production of cytokines and the activation
of MAPK and NF-κB pathways and; i) to select potential
immunomodulatory LAB that may be used to beneficially
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modulate the inflammatory response in bovine IECs chal-
lenged with heat-stable ETEC PAMPs.
Methods
BIE cells
The bovine intestinal epithelial cell line (BIE cells) was
originally derived from fetal bovine intestinal epithelio-
cytes, and then established as a SV40 large T antigen-
transformed intestinal cell line as previously described
[17]. BIE cells were maintained in Dulbecco’s modified
Eagle medium (DMEM; GIBCO, Grand Island, NY)
containing 10% heat-inactivated fetal bovine serum
(FBS) and penicillin-streptomycin until it they were used
for further studies. For the passage, BIE cells were
treated with a sucrose/EDTA buffer (0.1M Na2HPO4/
12H2O, 0.45M Sucrose, 0.36% EDTA/4Na, BSA) for 4
min, detached using 0.04% trypsin in phosphate-buffered
saline (PBS, pH7.2) [18]. Then, BIE cells were plated in
collagen type I-coated culture dishes (Sumilon, Tokyo,
Japan) at 1.5×104 cells/cm2 and cultured at 37°C in an
atmosphere of 5% CO2 in Dulbecco’s Modified Eagle
media (DMEM) (10% FCS, 1% streptomycin/penicillin,
100 U/ml streptomycin, high glucose, L-glutamine, 0.11
mg/ml sodium pyruvate; GIBCO).
Microorganisms
Enterotoxigenic Escherichia coli (ETEC) strain 987
(O9: H-: 987P+: STa+) was kindly provided by Dr. M.
Nakazawa, National Institute of Animal Health
(Tsukuba, Japan) [19]. ETEC cells were grown in blood
agar (5% sheep blood) for 24 hours at 37°C and then
transferred to tryptic soy broth (TSB; Becton, Dickinson
and Company, USA) for 5 days at 37°C without shaking
to get a pellicle containing piliated phase. ETEC cells
were collected from the pellicle and transferred to 1L
TSB and cultured 20 hours at 37°C with shaking. After
incubation, the subcultures of bacteria were centrifuged
at 5000 × g for 10 min at 4°C and washed with PBS
(pH7.2). Finally, ETEC cells were heat killed at 100°C for
15 minutes and then washed with PBS. Heat-stable
ETEC PAMPs were suspended in DMEM for use. The
following lactobacilli strains were used in this study:
Lactobacillus reuteri MEP221101 and MEP221102,
Lactobacillus casei MEP221103, OLL2768, MEP221104,
MEP221105, MEP221106, MEP221107, MEP221108,
MEP221109, MEP221114 and MEP221115, Lactobacillus
rhamnosus MEP221110, MEP221111, MEP221112 and
GG, Lactobacillus salivarius MEP221113, Lactobacillus
jensenii TL2937 and Lactobacillus gasseri MEP221117.
The lactobacilli strains were grown in de Man, Rogosa
and Sharpe (MRS) medium (Difco, Detroit, USA) for
16 h at 37°C and washed with PBS (pH7.2), and heat
killed (60°C, 30 min). These bacterial samples were
resuspended in DMEM, enumerated using a Petroff-
Hausser counting chamber, and stored at −80°C until
use [14].
Immunocytochemistry
BIE cells were cultured at a cell density of 3×104 cells/
well of a 12-well culture plate collagen type I-coated
glass disk (Iwaki Glass Co., Tokyo, Japan) for 3 days,
(37°C, 5% CO2). BIE cells were washed with cold PBS
(pH7.2) plus 2% FCS twice and then fixed with 4% para-
formaldehyde/PBS solution (room temperature, 5 mi-
nutes). Following treating with PBS-T (0.2% Triton X-
100) for 5 min at room temperature and washing three
times with PBS. Cells were then incubated with Alexa
488 conjugated rabbit anti-TLR2 polyclonal antibody
(bs-1019R-Alexa488, Bioss Inc., Wobum, MA, USA) or
Alexa 488 conjugated rabbit anti-TLR4 antibody (bs-
1021R-Alexa488, Bioss) diluted 50 times with Can Get
Signal solution 1 (NKB-201, TOYOBO Co., Ltd., Osaka,
Japan) overnight at 4°C. Both anti-TLR2 and anti-TLR4
antibodies cross-react with bovine receptors according
to Bioss Inc. datasheet. Alexa 488 conjugate rabbit IgG
(20304AF488, IMGENEX, San Diego, CA, USA) was
used as isotype control. Following washing three times
with PBS-T and the cells were rinsed in distilled water
and then mounted with FLUOROSHIELD with DAPI
(AR-6501-01, ImmunoBioScience Corp, Mukilteo, WA,
USA). Immunofluorescence microscopy was performed
with using a confocal laser microscope (LSM 700, Carl
Zeiss, Oberkochen, Germany).
Quantitative expression analysis of toll-like receptors by
real-time polymerase chain reactions (PCR) in BIE cells
We performed two-step real-time quantitative PCR to
characterize the expression of TLRs mRNAs in BIE cells.
Total RNA from each sample was isolated from the BIE
cells using TRIzol reagent (Invitrogen). All cDNAs were
synthesized from 5 μg of total RNA using a Quantitect
Reverse Transcription kit (Qiagen, Tokyo, Japan) accor-
ding to the manufacturer’s recommendations. Real-time
quantitative PCR was carried out using a 7300 Real-time
PCR System (Applied Biosystems, Warrington, UK)
using Platinum SYBR Green qPCR SuperMix Uracil-
DNA Glycosylase (UDG) with Fast Start Universal SYBR
Green Master (ROX) (Invitrogen). The primers for TLRs
used in this study are described in Table 1. The PCR
cycling conditions were 5 min at 50°C; followed by
5 min at 95°C; then 40 cycles of 15 sec at 95°C, 30 sec at
60°C and 30 sec at 72°C. The reaction mixture contained
5 μl of the sample cDNA and 15 μl of the master mix
including the sense and antisense primers. Expression
of β-actin was used to normalize cDNA levels for
differences in total cDNA levels in the samples. TLRs
mRNA levels in BIE cells were calibrated by the bovine
β-actin level, and normalized by common logarithmic
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transformation in comparison to the TLR1 mRNA level
in BIE cells (as 1.00).
Anti-inflammatory assay in BIE cells
Lactobacilli were re-suspended in DMEM (10% FCS, 1%
SP), enumerated in a microscope using a Petroff-Hausser
counting chamber, and stored at −80°C until use. BIE cells
were plated at 3×104 cells/well of a 12-well ptype I
collagen-coated plates (Iwaki, Tokyo, Japan), and cultured
for three days. After changing medium, lactobacilli (5×107
cells/ml) were added and 48 hours later, each well was
washed vigorously with medium at least 3 times to
eliminate all the stimulants. Expression of cytokines,
chemokines and TLRs negative regulators were studied
first without any inflammatory challenge by using real
time PCR as described below. In addition, the effect of
lactobacilli on BIE cells immune response was studied
using heat-stable ETEC as inflammatory factor. BIE cells
were treated with heat-stable ETEC (final concentration:
5×107 cells/ml) for indicated time and the expression of
cytokines, chemokines and TLRs negative regulators were
studied by using real time PCR as described below. In
addition, activation of p38, c-Jun N-terminal kinase (JNK)
and extracellular signal-regulated kinase (ERK) mitogen-
Table 1 Primer sequences used in this study
Primer Sense primer Antisense primer Accession number
β-actin TGG ATT GGC GGC TCC AT GCT GAT CCA CAT CTG CTG GAA NM_173979
TLR1 CAT TCC TAG CAG CTA CCA CAA GCT TGG GCC ATT CCA AAT AAG TTC T NM_001046504
TLR2 GGG TGC TGT GTC ACC GTT TC GCC ACG CCC ACA TCA TCT NM_174197
TLR3 GGG CAC CTG GAG GTC CTT TTC CTG GCC TGT GAG TTC TTG NM_001008664
TLR4 AGC ACC TAT GAT GCC TTT GTC A GTT CAT TCC GCA CCC AGT CT NM_174198
TLR5 GTC CCC AAC ACC ACC AAG AG GCG GTT GTG ACT GTC CTG ATA TAG NM_001040501
TLR6 TTT ACC CTC AAC CAC GTG GAA GGG CCA AAG GAA CTG AAA AAC NM_001001159
TLR7 CAC CAA CCT TAC CCT CAC CAT T GTC CAG CCG GTG AAA GGA NM_001033761
TLR8 TGT GTT TAG AGG AAA GGG ATT GG TCT GCA TGA GGT TGT CGA TGA NM_001033937
TLR9 CAG TGG CCA GGG TAG TTT CTG CCG GTT ATA GAA GTG ACG GTT GT NM_183081
TLR10 TCT ACT GCA TCC CTA CCA GAT ATC C GGG CCA TTC CAA GTA TGC TTT NM_001076918
MCP-1 CAC CAG CAG CAA GTG TCC TAA A CAC ATA ACT CCT TGC CCA GGA T NM_174006
TNF-α CGC ATT GCA GTC TCC TAC CA GGG CTC TTG ATG GCA GAC A NM_173966
TGF-β CGT GGA GCT GTA CCA GAA ATA TAG C CGA GCA GCC GGT TGC T NM_001166068
IFN-α GGT GGC AGC CAG TTA CAG AAG TGC TGG GTC ACC TCA TGG A Z46508
IFN-β CGA TGG TTC TCC TGC TGT GTT GAG CAA GCT GTA GCT CCT GGA A EU276065
IFN-γ GGA GGA CTT CAA AAA GCT GAT TCA GGC TTT GCG CTG GAT CTG NM_174086
LIF CTG TCC CAG CAA CCT CAT GA TGG CAC TGC TGT TGA GTT GTC NM_173931
IL-1α CAG TTG CCC ATC CAA AGT TGT T TGC CAT GTG CAC CAA TTT TT NM_174092
IL-1β GAG CCT GTC ATC TTC GAA ACG GCA CGG GTG CGT CAC A NM_174093
IL-4 GCC ACA CGT GCT TGA ACA AA TGC CAA GCT GTT GAG ATT CCT NM_173921
IL-6 CCA CCC CAG GCA GAC TAC TTC CCA TGC GCT TAA TGA GAG CTT NM_173923
IL-7 CAA GCT TCA CCT ATC AAC AGT TTC A CCC TTG CTG GTG CAG TTC A NM_173924
IL-8 TGC TCT CTT GGC AGC TTT CC TCT TGA CAG AAC TGC AGC TTC AC NM_173925
IL-10 GGC GGT GGA GAA GGT GAA GGC TTT GTA GAC ACC CCT CTC TT NM_174088
IL-12 CAG CAA GCC CAG GAA GGA TGA CAG CCC TCA GCA GGT TT NM_174355
MKP-1 CGCAGCGCGCAAATCT CGGGTAGGAAGCAGAAAAAGC NM_001046452
IRAK-M ACAGCGGAGCGGCTTTC CTTGGTCTACATATTTTTCAATGTGA NM_001190299
SIGIRR GGCAGTGAAGTGGATGTGTCA TCCGTGCGGGCACTGTA NM_001082443
BCL3 CATGGAACACCCCCTGTCA GGCGTATCTCCATCCTCATCA NM_001205993
Tollip CGGGCGTGGACTCTTTCTAC GATGCGGTCGTCCATGGA NM_001039961
ABIN-3 CGCAGAACGAATTGCTGAAA CACTACGCTCCCTCTGGAAGTC BC102932
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activated protein kinases and NF-кB pathways were stud-
ied by using western blotting as described below. In these
experiments, the synthetic TLR2 agonist tripalmitoylated
lipopeptide Pam3CysSerLys4 (Pam3CSK4) was also used.
BIE cells were stimulated with Pam3CSK4 (final concen-
tration: 200 ng/ml) for the indicated time same as the
other stimuli.
Quantitative expression analysis of cytokines, chemokines
and TLRs negative regulators by PCR in BIE cells
Two-step real-time quantitative PCR was used to
characterize the expression of cytokines, chemokines and
TLRs negative regulators mRNAs in BIE cells. Total RNA
from each sample was isolated from the BIE cells using
TRIzol reagent (Invitrogen). All cDNAs were synthesized
from 5 μg of total RNA using a Quantitect Reverse Trans-
cription kit (Qiagen, Tokyo, Japan) according to the manu-
facturer’s recommendations. Real-time quantitative PCR
was carried out using a 7300 Real-time PCR System
(Applied Biosystems, Warrington, UK) using Platinum
SYBR Green qPCR SuperMix UDG with ROX
(Invitrogen). The primers for cytokines, chemokines and
TLRs negative regulators used in this study are described
in Table 1. The PCR cycling conditions were 5 min at
50°C; followed by 5 min at 95°C; then 40 cycles of 15 sec
at 95°C, 30 sec at 60°C and 30 sec at 72°C. The reaction
mixture contained 5 μl of the sample cDNA and 15 μl of
the master mix including the sense and antisense primers.
Expression of β-actin was used to normalize cDNA levels
for differences in total cDNA levels in the samples. TLRs
mRNA levels in BIE cells were calibrated by the bovine β-
actin level, and normalized by common logarithmic trans-
formation in comparison to the each control (as 1.00).
Enzyme linked immunosorbent assay (ELISA) for the
detection of cytokines
BIE cells were stimulated with L. casei OLL2768 or
MEP221108 (5×107 cells/ml) for 48 hr and then chal-
lenged with heat-stable ETEC PAMPs as described before.
The concentration of IL-6 and MCP-1 secreted into the
supernatant of BIE cell cultures was determined using two
commercially available enzyme- linked immunosorbent
assay (ELISA) kits (bovine IL-6 [ESS0029, Thermo Scien-
tific, Rockford, IL, USA] and bovine CCL2/MCP-1 [E11-
800, Bethyl Laboratories, Inc. Montgomery, TX, USA]),
according to the manufacturers’ instructions.
Western Blotting
BIE cells cultured in 1.8×105 cells/60 mm dishes
were stimulated with Lactobacillus casei OLL2768 or
Pam3CSK4 with same time schedule and equivalent
amount as mentioned above. BIE cells were then washed
and stimulated with heat-stable ETEC PAMPs for indi-
cated time. After stimulation, BIE cells were washed
three times with PBS and resuspended in 200 μl of
CelLytic M Cell Lysis Reagent (Sigma-Aldrich, St. Louis,
MO, USA) including protease and phosphates inhibi-
tors (complete Mini, PhosSTOP: Roche, Mannheim,
Germany). Protein concentration was measured with
BCA protein assay kit (Pierce, Rockford, IL, USA). Ex-
tracts (120 μl) were transferred into Eppendorf tubes
and were added with 40 μl of Sample Buffer Solution
(2ME+)(×4)(Wako), and boiled for 5 min at 95°C. Equal
amounts of extracted proteins (2 μg) were loaded on
10% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). Separated proteins were transferred electrophor-
etically to a PVDF membrane. The membrane was
blocked with 2% BSA/TBS-T (w/v) for 2 hours at room
temperature. Phosphorylation of p38, JNK and ERK
mitogen-activated protein kinases and nuclear factor
kappa B inhibitor protein (IkB) degradation were evalu-
ated using Phospho-p38 MAPK (Thr180/Tyr182) anti-
body (p-p38, Cat. #9211); p38 MAPK antibody (p38,
Cat. #9212); Phospho-SAPK/JNK (Thr183/Tyr185) anti-
body (p-JNK, Cat. #9251); SAPK/JNK antibody (JNK,
Cat. #9252); Phospho-p44/42 MAP kinase (Thr202/
Thy204) antibody (p-ERK, Cat. #9101); p44/42 MAP
(Erk 1/2) antibody (ERK, Cat. #9102) and; I kappaB-
alpha antibody (IkBa, Cat. #9242) from Cell Signaling
Technology (Beverly, MA, USA) at 1000 times dilution of
their original antibodies and with immunoreaction enhan-
cer (Can Get SignalW Solution 1, TOYOBO Co. Ltd.,
Osaka, Japan) overnight at room temperature. After wash-
ing with TBS-T, the membrane was incubated alkaline
phosphatase conjugated anti-rabbit IgG (Cat. #A3937,
Sigma) at 2000 times dilution with immunoreaction en-
hancer (Can Get SignalW Solution 2, TOYOBO Co. Ltd.,
Osaka, Japan) for 1 hour at room temperature. After
washing with TBS-T, signals were generated by overlaying
the membrane with ECF™ substrate (GE Healthcare,
Piscataway, NJ, USA) for 5 min at room temperature
under dark conditions. The Attophos (Ex; 440nm, Em;
560nm) was detected by Molecular Imager Fx (Bio-Rad,
Hercules, CA, USA). The densitometry of western blots
was carried out by using Image J software (National Insti-
tutes of Health, Bethesda, MD, USA).
Statistical analysis
Normalized relative expression of each control data
(showed as the ratio to β-actin mRNA expression) was
transferred to a normal distribution with a mean of 1.0.
In order to normalize the control data, they were fitted
by using the following function:
Z xið Þ ¼ xi $ x controlð Þ $ σx
! "
=σx
Z(xi): all adjusted data; xi: i
th experimental data, x(con-
trol): a mean of repeated control data; and σx was a
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standard deviation of repeated control or trial data.
Similarly, normalized relative expression for heat-stable
ETEC PAMPs and lactobacilli data was fitted to this
function to show them as a fold value compared to the
control data. Each of data number repeated in a same
condition was from 8 to 10. Statistical analysis was
performed by using SAS computer program, ver.6.0 and
GLM procedure. The multiple comparisons among
means of fold expression were carried out by Fisher’s
least significance differential test, LSD method. Diffe-
rences were significant at 5% level and were showed in
graphs with superscripts letters (for differences between
means) or asterisks (for differences between each treat-
ment a control).
Results
Expression of TLRs in BIE cells
In order to study the mechanisms by which bovine IECs
induce immune responses against intestinal pathogens,
we have previously established a clonal bovine intesti-
nal epithelial cell line (BIE cells). When BIE cells are
cultured they assume monolayer cobblestone and
epithelial-like morphology with close contact between
the cells [17]. Moreover, scanning electron microscopy
examination of BIE cell reveled that 3-days old cells have
irregular and slender microvilli-like structures on their
surface and that this structures increase in complexity as
the cells grow [17]. In this work, we applied real-time
quantitaive PCR to analyze the expression of TLRs
mRNA in BIE cells. All TLRs genes were expressed in
BIE cells (Figure 1A). Among TLR family, TLR1, 3, 4
and 6 were strongly expressed, followed by TLR5, 8, 9,
10, 2 and 7. We were particularly interested in expres-
sion of TLR2 and TLR4 as the main receptors detecting
LAB and ETEC respectively. Therefore, to confirm these
real-time PCR findings, we further examined the expres-
sion of TLR2 and 4 proteins in BIE cells using anti-TLRs
antibodies that are able to cross-react with bovine TLRs
(Figure 1B). Visualization of the immunofluorescense
staining confirmed the protein expression of TLR2 and 4
in BIE cells (Figure 1B).
Study of the inflammatory response in BIE cells
stimulated with heat-stable ETEC PAMPs
We next investigated the response of BIE cells to heat-
stable ETEC PAMPs challenge. The ETEC 987P strain used
in this study does not express flagellin and we have demon-
strated that the main molecule responsible for the inflam-
matory response triggered by this bacterium is the LPS
present on its surface [14,15]. BIE cells were cultured for 3
days and then challenged with heat-stable ETEC PAMPs.
Twelve hours after stimulation we determined mRNA
levels of several cytokines (Figure 2A). Stimulation of BIE
cells with heat-stable ETEC PAMPs significantly increased
the expression of pro-inflammatory cytokines MCP-1, IL-
1α, IL-1β, IL-6 and IL-8 and the levels of IFN-β (Figure 2A).
Figure 1 Analysis of toll-like receptors (TLRs) expression in bovine intestinal epithelial (BIE) cells. (A) TLR1-10 mRNA levels in BIE cells. The
expression of TLR in BIE cells was calculated first as relative units compared to bovine β-actin level. After calculating the relative unit to β-actin,
TLR1 was set as 1. Values represent means and error bars indicate the standard deviations. The results are means of six independent experiments.
(B) Immunofluorescent localization of TLR2 and TLR4 in BIE cells. Green images indicate bovine TLR2 or TLR4 positive cells and nuclei in all panels
were stained with DAPI (blue). Control experiments were performed by omitting the primary antibody. The results represent six independent
experiments.
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We also evaluated the mRNA levels of IL-1α, IL-1β, IL-
6IL-8, TNF and MCP-1 at different times after stimulation
with heat-stable ETEC PAMPs, with the aim of establishing
the most appropriate time to study the inflammatory re-
sponse. After the challenge with heat-stable ETEC PAMPs,
levels of IL-1α, IL-1β, IL-6, IL-8, and MCP-1 increased pro-
gressively in BIE cells until the hour 12 post-stimulation
(Figure 2B). On the contrary, mRNA levels of TNF in BIE
cells stimulated with heat-stable ETEC PAMPs were in-
creased earlier at hour 3 (Figure 2B). Considering these re-
sults, we selected the hour 12 post-stimulation for the
following experiments.
Selection of lactobacilli strains able to modulate
inflammatory response in BIE cells
Recently, we have demonstrated that stimulation with
Lactobacillus jensenii TL2937 is able to down-regulate the
levels of IL-6, IL-8 and MCP-1 produced by porcine IECs
in response to heat-stable ETEC PAMPs or LPS challenges
[14]. Moreover, we demonstrated that TLR2 is partially in-
volved in this immunoregulatory effect of L. jensenii
TL2937 in PIE cells [14]. Then, we next aimed to evaluate
if this immunobiotic strain has a similar effect on BIE
cells. For this reason, BIE cells were stimulated for 12, 24
or 48 hours with L. jensenii TL2937 or the synthetic TLR2
agonist Pam3CSK4 and then challenged with heat-stable
ETEC PAMPs. Twelve hours after stimulation levels of
MCP-1, IL-8 and IL-6 were evaluated (Figure 3A). Stimu-
lation of BIE cells for 12 h with L. jensenii TL2937 or
Pam3CSK4 significantly increased the production of IL-8
in response to heat-stable ETEC PAMPs challenge in hour
12 post-stimulation. On the contrary, levels of IL-8 were
significantly lower in cells treated for 48 h with L. jensenii
TL2937 or Pam3CSK4. MCP-1 levels were significantly
Figure 2 Expression of cytokines in bovine intestinal epithelial (BIE) cells after stimulation with heat-stable Enterotoxigenic Escherichia
coli (ETEC) pathogen-associated molecular patterns (PAMPs). (A) BIE cells were challenged with heat-stable ETEC PAMPs and twelve hours later
the expression of several cytokines was studied. The results represent four independent experiments. Significantly different from control *(P<0.05), **
(P<0.01). (B) BIE cells were challenged with heat-stable ETEC PAMPs and the expression of MCP-1, TNF, IL-1-α, IL-β, IL-6 and IL-8 was studied at the
indicated times post-stimulation. The results represent four independent experiments. Significantly different from time 0 *(P<0.05), **(P<0.01).
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Figure 3 Evaluation of the immunomodulatory activity of lactobacilli. (A) Bovine intestinal epithelial (BIE) cells were pre-treated with
immunobiotic Lactobacillus jensenii TL2937 or Pam3CSK4 for 12, 24 or 48 hours, stimulated with heat-stable ETEC PAMPs and then the expression
of MCP-1, IL-6 and IL-8 was studied at hour twelve post-stimulation. Significantly different from ETEC Control *(P<0.05). (B) Levels of MCP-1 and
IL-6 proteins. BIE cells were pre-treated with Lactobacillus casei OLL2768 or L. casei MEP221108 for 48 hours and the stimulated with heat-stable
ETEC PAMPs and then levels of MCP-1 and IL-6 was studied at hour twelve post-stimulation. Significantly different from ETEC Control *(P<0.05).
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higher than controls in BIE cells treated for 12 h with
Pam3CSK4 or 24 h with L. jensenii TL2937 (Figure 3A).
BIE cells pre-stimulated with L. jensenii TL2937 or
Pam3CSK4 during 24 h showed significantly reduced
levels of IL-6 (Figure 3A).
These results indicate that it is possible to modulate
the inflammatory response in BIE cells by using LAB.
Then, we next aimed to evaluate the potential anti-
inflammatory effect of 20 lactobacilli strains in BIE cells
with the aim of finding the strain with the highest im-
munomodulatory capacity in the bovine system. First,
we evaluated the effect of lactobacilli on BIE cells with-
out any inflammatory challenge (Additional file 1: Figure
S1A). BIE cells were treated with the different lactoba-
cilli strains for 48 h and the levels of mRNA IL-6, IL-8
and MCP-1 were determined. Only the strain
MEP221102 slightly increased levels of MCP-1, and
MEP221108 and MEP221114 also slightly increased
levels of IL-6 in BIE cells (Additional file 1: Figure S1A).
On the contrary, several strains were able to significantly
down-regulate the levels of IL-8 in BIE cells (Additional
file 1: Figure S1A). Next, we evaluated the effect of
lactobacilli on BIE cells using heat-stable ETEC PAMPs
as inflammatory factor (Additional file 1: Figure S1B).
For this purpose, BIE cells were stimulated with the dif-
ferent LAB strains for 48 h, challenged with heat-stable
ETEC PAMPs and the levels of the three pro-
inflammatory cytokines were studied at hour 12 post-
stimulation. MCP-1, IL-6 and IL-8 levels in BIE cells
stimulated with OLL2768, MEP221101, MEP221105 and
MEP221111 strains were significantly lower than those
observed in the control. On the contrary, the other
strains tested reduced one of the cytokines studied or
had no effect (Additional file 1: Figure S1B). Considering
that L. casei OLL2768 and L. casei MEP221111 showed
the highest capacity to down-regulate IL-8 and also were
able to reduce IL-6 and MCP-1 after heat-stable ETEC
PAMPs challenge, one of these strains (L. casei
OLL2768) was selected for the following experiments.
To further confirm the immunoregulatory effect of L.
casei OLL2768 and to obtain transcriptional data sup-
ported by protein detection of selected cytokines, we
conducted ELISAs to evaluate the levels of IL-6 and
MCP-1 proteins (Figure 3B). BIE cells were stimulated
with L. casei OLL2768 or L. casei MEP221108 (negative
control) and 48 h after were challenged with heat-stable
ETEC PAMPs. Challenge significantly increased levels of
both IL-6 and MCP-1 proteins. Pretreatment of BIE cells
with L. casei OLL2768 significantly reduced levels of
MCP-1, however L. casei MEP221108 was not able to
modify MCP-1 values (Figure 3B). Both L. casei
OLL2768 and MEP221108 were able to reduce levels of
IL-6 after the challenge with heat-stable ETEC PAMPs,
however the effect of L. casei OLL2768 was significantly
higher than those observed for MEP221108. In addition,
we evaluated if the TLR2 agonist Pam3CSK4 was able to
modulate IL-6 and MCP-1 synthesis. BIE cells pretreated
Pam3CSK4 showed reduced levels of both cytokines
after heat-stable ETEC PAMPs challenge (Figure 3B).
Effect of L. casei OLL2768 on MAPK and NF-κB pathways
in BIE cells
We next evaluated whether L. casei OLL2768 was able
to attenuate heat-stable ETEC PAMPs-mediated pro-
inflammatory responses by modulating the NF-κB path-
way. Challenge of BIE cells with heat-stable ETEC
PAMPs significantly reduced the levels of the counter-
regulatory factor IκBα (Figure 4). BIE cells previously
stimulated with L. casei OLL2768 or Pam3CSK4 did not
show a significant degradation of IκBα indicating an in-
hibitory effect in NF-κB pathway (Figure 4). We also ex-
amined the relationship between MAPK activation and
regulation of pro-inflammatory cytokines in BIE cells by
L. casei OLL2768 (Figure 5). BIE cells were stimulated
with OLL2768 strain, Pam3CSK4 or control medium
and the activation profiles of p38, ERK and JNK were
compared. As shown in Figure 5A and B, heat-stable
ETEC PAMPs induced the phosphorylation of p38 and
ERK, which reached a maximum between 5 and 10 mi-
nutes. The time course of ERK phosphorylation induced
by heat-stable ETEC PAMPs in BIE cells treated with
Pam3CSK4 showed a similar tendency to that observed
in the control. On the contrary, reduced phosphoryl-
ation of p38 was observed in Pam3CSK4- and L. casei
OLL2768-treated BIE cells (Figure 5A, B). In addition, in
L. casei OLL2768- treated BIE cells a delayed increase of
p-ERK was observed when compared to control. In L.
casei OLL2768-treated cells the levels of p-ERK were
significantly increased 10 min after heat-stable ETEC
PAMPs challenge (Figure 5C). The time course of JNK
phosphorylation induced by heat-stable ETEC
PAMPs in BIE cells treated with Pam3CSK4 showed
a similar tendency to that observed in the control
(Figure 5C). In L. casei OLL2768- treated BIE cells,
phosphorylation of JNK significantly increased at mi-
nutes 5 and 10 after heat-stable ETEC PAMPs chal-
lenge. In addition, the levels of p-JNK decreased at
minutes 20 and 40 in L. casei OLL2768-treated BIE
cells, showing a difference with the control cells
(Figure 5C).
Effect of L. casei OLL2768 on negative regulators of the
TLRs signaling pathway in BIE cells
We studied the negative regulators that are known to me-
diate the TLR signaling pathway. First, we aimed to evalu-
ate the changes in TLRs negative regulators without any
pro-inflammatory challenge. For this reason, BIE cells
were stimulated for 12, 24, 36 or 48 hours with L. casei
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OLL2768 or Pam3CSK4 and the expression of single im-
munoglobulin IL-1-related receptor (SIGIRR), Toll
interacting protein (Tollip), A20-binding inhibitor of nu-
clear factor kappa B activation 3 (ABIN-3), B-cell lymph-
oma 3-encoded protein (Bcl-3), mitogen-activated protein
kinase 1 (MKP-1) and interleukin-1 receptor-associated
kinase M (IRAK-M) was determined by real-time PCR.
None of the treatments were able to significantly in-
duce changes in the expression of SIGIRR, ABIN-3 or
IRAK-M (Figure 6A). We observed a slightly increase
of MKP-1 after 24 hours of stimulation with both L.
casei OLL2768 or Pam3CSK4, however this increase
was not maintained after 36 hours. In addition, both
treatments were capable of up-regulate the expression
of Tollip after 48 h post-stimulation (Figure 6A). The
expression of Bcl-3 was significantly up-regulated
after 36 h post-stimulation with Pam3CSK4 or 48 h
with Pam3CSK4 and L. casei OLL2768 (Figure 6A).
We next evaluated the changes in the expression of
TLR negative regulators after the challenge with heat-
stable ETEC PAMPs. Again, BIE cells were treated
with L. casei OLL2768 or Pam3CSK4 for 48 hours
and stimulated with heat-stable ETEC PAMPs. No
changes were observed in the expression of IRAK-M
and ABIN-3 with either treatment (Figure 6B). MKP-
1 was significantly up-regulated in OLL2768-treated
BIE cells only in hour 6 post-challenge. In addition,
the stimulation of BIE cells with Pam3CSK4 increased
expression levels of SIGIRR and Tollip at hour 6
post-stimulation with heat-stable ETEC PAMPs. On
the other hand, BIE cells treated with L. casei
OLL2768 showed significantly higher levels of Bcl-3
and Tollip during all the studied period when com-
pared to untreated control BIE cells (Figure 6B).
Discussion
Although once considered simply a physical barrier, it is
becoming increasingly evident that the epithelium plays
as a crucial regulator of intestinal immune homeostasis.
In response to invasive bacteria, IECs may produce a
variety of cytokines and chemokines that play a crucial
role in both the innate and adaptive immune responses
in the gut [20]. In this paper, in order to understand the
functional role of the bovine intestinal epithelium in mu-
cosal host defense as part of the immune system, we
studied in BIE cells the expression of TLRs and charac-
terized heat-stable ETEC PAMPs-induced signal trans-
duction pathways and cytokine induction. It is known
that IECs are able to respond to pathogenic microorgan-
isms because their expression of pattern recognition re-
ceptors (PRRs) such as TLRs. Therefore, the first aim of
our research was to investigate the expression of TLRs
in BIE cells. We found that TLR4 was one of the most
highly expressed TLRs in BIE cells. TLR4 is conserved
among different species and its expression appears to be
a characteristic feature of IECs [21], therefore, the pres-
ence of TLR4 in BIE cells resembles IECs of other
species.
The inflammatory response triggered by the activation
of TLR4 in IECs play a critical role in host defense
against Gram(−) pathogens. In this study, we showed
that heat-stable ETEC PAMPs from strain 987P signifi-
cantly enhanced the production of IL-6, IL-8, IL-
1α and MCP-1 in BIE cells by activating both NF-κB and
Figure 4 Western blot analysis of IκB degradation on bovine intestinal epithelial (BIE) cells after challenge with heat-stable
Enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs). BIE cells were pre-treated with Lactobacillus casei
OLL2768 or Pam3CSK4 for 48 hours and then stimulated with heat-stable ETEC PAMPs or LPS. Levels of the counter-regulatory factor IκBα were
studied at the indicated times post-stimulation. Significantly different from time 0 *(P<0.05).
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Figure 5 (See legend on next page.)
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Figure 6 Expression of toll-like receptor negative regulators in bovine intestinal epithelial (BIE) cells. (A) BIE cells were stimulated with
Lactobacillus casei OLL2768 or Pam3CSK4 for 12, 24, 36 or 48 hours and the expression of MKP-1, IRAK-M, SIGIRR, Bcl-3, Tollip and ABIN-3 negative
regulators was studied. The results represent four independent experiments. Significantly different from control at the same time point *(P<0.05).
(B) BIE cells were pre-treated with Lactobacillus casei OLL2768 or Pam3CSK4 for 48 hours and then stimulated with heat-stable Enterotoxigenic
Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs). The expression of MKP-1, IRAK-M, SIGIRR, Bcl-3, Tollip and ABIN-3 negative
regulators was studied at the indicated times post-heat-stable ETEC PAMPs challenge. The results represent four independent experiments.
Significantly different from ETEC control at the same time point *(P<0.05), **(P<0.01).
(See figure on previous page.)
Figure 5 Western blot analysis of p38, JNK and ERK mitogen-activated protein kinases activation on bovine intestinal epithelial (BIE)
cells after challenge heat-stable Enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs). BIE cells were
pre-treated with Lactobacillus casei OLL2768 or Pam3CSK4 for 48 hours and then stimulated with heat-stable ETEC PAMPs or LPS. Phosphorylation
of p38, JNK and ERK was studied at the indicated times post-stimulation. Significantly different from time 0 *(P<0.05).
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MAPK pathways. These findings correlate with our pre-
vious observations since we demonstrated that the heat-
killed ETEC 987P strain, which does not express flagellin,
triggers a TLR4-mediated inflammatory response in por-
cine intestinal epithelial cells through its LPS [21]. More-
over, the findings of the present work correlate with
studies of the immune response against ETEC in IECs of
different hosts species. It was shown that both NF-κB and
MAPK pathways are important mediators of ETEC and
LPS activation in human (HT29 and T84), mouse
(CMT93) and porcine (PIE) IECs [14,22].
The cytokines produced by BIE cells may have an im-
portant protective role during ETEC infection. The en-
hanced secretion of IL-8 stimulates the strong infiltration
of neutrophils in the lamina propria that is observed upon
ETEC infection. Following IL-8 induced recruitment of
neutrophils IL-6 can induce degranulation of these cells,
thereby enhancing the inflammatory response [23]. On the
other hand, IECs are able to produce MCP-1 in res-
ponse to ETEC challenge. This chemokine has potent
monocytes-activating and attracting propierties and plays a
major role during intestinal inflammation [24]. Therefore,
our findings indicate that BIE cells are useful cell line for
studying inflammatory responses via TLR4 in vitro. More-
over, taking into consideration that inflammatory responses
induced by intestinal pathogens can lead to dysregulation
of IECs signaling, disruption of membrane barrier integrity,
enhancement of pathogen translocation and disease [5],
BIE cells could be also used to evaluate therapies designed
for preventing inflammatory damage caused by heat-stable
ETEC PAMPs during ETEC infection.
Several reports have demonstrated that immunobiotic
LAB are able to improve resistance against pathogens
and to protect against inflammatory damage caused by
the infectious process [25-27]. Therefore we next aimed
to evaluate if an immunobiotic lactobacillus strain could
regulate the inflammatory response induced by heat-
stable ETEC PAMPs in BIE cells. Our laboratory has re-
cently found that L. jensenii TL2937 has a high capacity
to down-regulate IL-6 and IL-8 production by PIE cells
in response to heat-stable ETEC PAMPs or LPS chal-
lenges [14]. For these reasons, we first focused on L.
jensenii TL2937 to evaluate its anti-inflammatory effect
in BIE cells. L. jensenii TL2937 is able to decrease IL-6
(20% lower than control) and IL-8 (25% lower than con-
trol) expressions in heat-stable ETEC PAMPs-challenged
BIE cells. However, this effect was lower when compared
with the immunomodulatory activity of this strain in
porcine IECs [14]. In heat-stable ETEC PAMPs-
challenged porcine IECs previously treated with L.
jensenii TL2937 the expression of IL-6 and IL-8 were
35% and 30% lower than control respectively [14]. Al-
though the effect of L. jensenii TL2937 in BIE cells was
lower than the previously described in porcine IECs, the
present study indicate that LAB strains could be benefi-
cial for attenuating inflammatory damage caused by
heat-stable ETEC PAMPs in BIE cells. Thus, we next
aimed to select the most effective strains of lactobacilli
able to modulate heat-stable ETEC PAMPs-mediated in-
flammatory response in BIE cells. Several strains were
evaluated in our system and we found that some lacto-
bacilli were able to down-regulate the expression of in-
flammatory cytokines. Among these strains, L. casei
OLL2768 showed the most pronounced effect. Of inter-
est, we showed that the immunoregulatory effect of L.
casei OLL2768 in BIE cells was more pronounced than
that observed for L. jensenii TL2937, while the effect of
OLL2768 strain was lower in porcine IECs [14]. Then,
our findings indicate that is appropriate to evaluate dif-
ferent strains carefully according to the specific host, be-
cause the effect of the same LAB strain may differ
according to the host that consumes it. In this sense, our
in vitro bovine system can be of great value to find
immunobiotic LAB strains suitable on the bovine host.
In BIE cells, L. casei OLL2768 attenuated heat-stable
ETEC PAMPs-induced pro-inflammatory response and
we confirmed that these effects were related to the cap-
acity of OLL2768 strain to inhibit NF-κB and p38 signal-
ing pathways in heat-stable ETEC PAMPs-challenged BIE
cells. These results are reminiscent of other studies show-
ing that probiotics are able to suppress TNF- or S.
typhimurium- induced IL-8 gene expression and secretion
by IECs in a NF-κB-dependent manner [28,29]. Moreover,
our experiments extended these findings by showing that
LAB are able to inhibit p38 signaling pathway in heat-
stable ETEC PAMPs-challenged bovine IECs.
The JNK and p38 MAPK pathways share several up-
stream regulators, and accordingly there are multiple
stimuli that simultaneously activate both pathways. Then
we expected that L. casei OLL2768 had the same effect
on JNK as they had in p38 pathway. However, we found
an opposite behavior in JNK pathway. While in L. casei
OLL2768-treated BIE cells the phosphorylation of p38
was reduced after challenge with heat-stable ETEC
PAMPs, increased levels of p-JNK were detected. It was
shown that these two stress-activated signaling pathways
induce opposite effects and there is evidence indicating
that the p38 MAPK pathway can negatively regulate
JNK activity in several contexts [30,31]. In fact, the first
evidence for this crosstalk was the observation that
chemical inhibition of p38α and p38β strongly increased
the activation of JNK, which was induced by IL-1 and
sorbitol in epithelial cells and by LPS in macrophages
[31]. Moreover, the kinetic analysis of our results showed
an up-regulation of p-p38 between 5 and 10 minutes after
heat-stable ETEC PAMPs challenge that was followed by a
down-regulation of p-JNK between 10 and 20 minutes.
Therefore, we can speculate that L. casei OLL2768 has a
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direct influence in p38 pathway while its effect in JNK is
the result of the inhibition of p38 phosphorylation. Further
research is needed to clarify completely the influence of L.
casei OLL2768 in MAPK pathways in heat-stable ETEC
PAMPs-challenged BIE cells.
Regulatory proteins can modulate the duration and in-
tensity of TLRs signals [32]. Consequently, to dissect the
mechanism(s) that underlie the anti-inflammatory effect
of L. casei OLL2768, we evaluated the effect of this
strain on the expression of the TLRs negative regulators
in BIE cells. We observed that L. casei OLL2768 can
negatively regulate TLR4 signaling in BIE cells by up-
regulating Tollip and Bcl-3 proteins. Bcl-3 functions as
an inhibitor of NF-κB activity by stabilizing repres-
sive NF-κB homodimers in a DNA-bound state and
preventing the binding of transcriptionally active dimers.
In fact, stabilization of repressive complexes through the
induction of Bcl-3 expression has been proposed to
function in the processes of LPS tolerance [33]. On the
other hand, it was demonstrated that overexpression of
Tollip impairs TLR4-triggered NF-кB and MAPK signal-
ing pathways and that inhibition of TLR signaling by
Tollip is mediated through its ability to suppress the ac-
tivity of IL-1 receptor-associated kinase (IRAK) [34,35].
Moreover, it was showed that prior exposure of IECs to
a TLR ligand, such as LPS, induces a hyporesponsive
state to a second challenge with the same or another
TLR ligand by selectively limiting pro-inflammatory
Figure 7 Proposed mechanism for the anti-inflammatory effect of Lactobacillus casei OLL2768 in bovine intestinal epithelial (BIE) cells
after challenge heat-stable Enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs).
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responses through up-regulation of Tollip and subse-
quent suppression of IRAK [35]. Therefore, the induc-
tion of Bcl-3 and Tollip by L. casei OLL2768 in BIE cells
is important in establishing NF-κB- and MAPK-medi-
ated tolerance against heat-stable ETEC PAMPs.
At present, we cannot provide the conclusive mechanism
for the anti-inflammatory action of L. casei OLL2768 on
BIE cells. However, we can hypothesize that when L. casei
OLL2768 encounters BIE cells it interacts with one or more
PRRs and induces the up-regulation of Bcl-3 and Tollip
negative regulators (Figure 7). Then, BIE cells pretreated
with this immunobiotic strain produce lower concentra-
tions of inflammatory mediators in response to heat-stable
ETEC PAMPs challenge that could help to limit the inflam-
matory damage. One of the possible PRR involved in the
anti-inflammatory effect of L. casei OLL2768 could be
TLR2 since our comparative studies with Pam3CSK4 de-
monstrated that treatment of BIE cells with the TLR2 ago-
nist up-regulate the expression of Tollip and reduce
activation of NF-κB and p38 MAPK pathways. Moreover, it
was found that LPS cross-tolerance may be induced by pre-
exposure to lipoteichoic acid which leads to up-regulation
of the common checkpoint Tollip via TLR2 [36]. However,
further research is needed to resolve which PRR is activated
by L. casei OLL2768 for the induction of negative
regulators.
Conclusion
We firstly reported in this study that BIE cells are useful
for studying in vitro inflammatory responses in the bovine
gut epithelium triggered by activation of TLR4. We also
demonstrated that BIE cells can be used for the selection
of immunomodulatory LAB and for studying the mecha-
nisms involved in the protective activity of immunobiotics
against pathogen-induced inflammatory damage, provi-
ding useful information that may be used for the develop-
ment of new immunologically functional feeds through
the screening and precise selection of lactobacilli strains
that are able to beneficially modulate the immune system
in the bovine host. In addition, we showed that L. casei
OLL2768 functionally modulate the bovine intestinal epi-
thelium by attenuating heat-stable ETEC PAMPs-induced
NF-κB and MAPK activation and pro-inflammatory cyto-
kines expression. Therefore L. casei OLL2768 is a good
candidate for in vivo studying the protective effect of LAB
against intestinal inflammatory damage induced by ETEC
infection or heat-stable ETEC PAMPs challenge in the bo-
vine host.
Additional file
Additional file 1: Figure S1. Selection of immunomodulatory
lactobacilli. (A) BIE cells were pre-treated with different lactobacilli strains
for 48 hours and the expression of MCP-1, IL-6 and IL-8 was studied.
Values represent means and error bars indicate the standard deviations.
The results represent five independent experiments. Significantly different
from control *(P<0.05). (B) BIE cells were pre-treated with different
lactobacilli strains for 48 hours and the stimulated with heat-stable ETEC
PAMPs and then the expression of MCP-1, IL-6 and IL-8 was studied at
hour twelve post-stimulation. Values represent means and error bars
indicate the standard deviations. The results represent five independent
experiments. Significantly different from ETEC control *(P<0.05).
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